Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 18/03/19981 min de lecture
Implantation or Injectable Dosage Form New Animal Drugs; Desoxycorticosterone Pivalate
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The NADA provides for use of desoxycorticosterone pivalate as replacement therapy for the mineralocorticoid deficit in dogs with primary adrenocortical insufficiency.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →